Redcare Pharmacy N.v. · XETR:RDC
Redcare Pharmacy — Shop Apotheke Europe — Merger or Acquisition (March 2023)
37 slides from Redcare Pharmacy's merger presentation, Mar 30, 2023
Slide 1: Joint Venture. Galenica & SHOP APOTHEKE EUROPE
Joint Venture. GALENICA & SHOP APOTHEKE EUROPE. Media & Analysts‘ Conference. Zurich, 30 March 2023. Disclaimer: Joint venture is subject to anti-trust clearance.
Slide 2: Agenda. Who is here today
Agenda. Who is here today. Introduction. Stefan Feltens, CEO SHOP APOTHEKE EUROPE. Presentation of GALENICA. Marc Werner, CEO GALENICA. Presentation of SHOP APOTHEKE EUROPE. Stefan Feltens, CEO SHOP APOTHEKE EUROPE. Presentation of Mediservice. André Lüscher, CEO Mediservice. Financial Details. Feli
Slide 3: Introduction
Introduction. Stefan Feltens, CEO SHOP APOTHEKE EUROPE.
Slide 4: The Strategic Partnership
The Strategic Partnership. Presentation of the Joint Venture between GALENICA and SHOP APOTHEKE EUROPE to create the leading online pharmacy in Switzerland with sales approaching half a billion Swiss francs / euros: A real B2C powerhouse. • Combining the business activities of Mediservice and shop-a
Slide 5: The Benefits
The Benefits. Mediservice and shop-apotheke.ch complement each other very well resulting in a more comprehensive range of products and services that guarantee an even better customer experience. • Merging of Mediservice’s specialty pharmacy expertise with SHOP APOTHEKE’s e-commerce proficiency. • Re
Slide 6: The Assignment
The Assignment. • Mediservice to take over the business activities of shop-apotheke.ch. • SHOP APOTHEKE EUROPE to hold 51% and GALENICA 49% of the joint venture. • GALENICA will receive an 8% stake in SHOP APOTHEKE EUROPE as part of a capital increase to finance the transaction.
Slide 7: Presentation of GALENICA
Presentation of GALENICA. Marc Werner, CEO GALENICA.
Slide 8: Improving the Customer Experience at All Levels
Improving the Customer Experience at All Levels. • We have reached a milestone in our Omni-Channel strategy! • We are further improving the customer experience and will meet the different needs of customers and patients even better in the future! • We create added value - in the Swiss healthcare mar
Slide 9: The Galenica Network: The Strongest and Leading Partners in the Swiss Healthcare Market
The Galenica Network: The Strongest and Leading Partners in the Swiss Healthcare Market. .
Slide 10: Galenica in Figures
Galenica in Figures. • Leading healthcare provider in Switzerland. • Net sales of CHF 4 billion and over CHF 200 million adjusted EBIT. • Employees > 7,600. • Share price development since IPO (2017): +76%.
Slide 11: Switzerland's Leading Fully-Integrated Healthcare Provider
Switzerland‘s Leading Fully-Integrated Healthcare Provider. Strongest network of Wide range of pharmacies in services for patients Switzerland with over in the pharmacy or at 500 pharmacies. home and professional service providers. Well-known own Leading provider of brands and products logistics and
Slide 12: The Galenica Story
The Galenica Story. Vision Health and wellbeing are at the heart of what we do. They are the reason we give our best every day. We build trust We show respect Values Together, we are stronger We act as entrepreneurs We participate with passion Customer We support people at every stage of life on the
Slide 13: Milestone in the Omni-Channel strategy
• Milestone in the Omni-Channel strategy. • Strong partners who complement each other ideally. • The leading pure online pharmacy in Switzerland. • Our customers benefit. • Our companies, employees and shareholder benefit. • Rapid, strong and profitable growth.
Slide 14: Milestone in Omni-Channel strategy. Improved customer experience
• Milestone in Omni-Channel strategy. • Improved customer experience. • Added value. Sustainable!
Slide 15: Presentation of SHOP APOTHEKE EUROPE
Presentation of SHOP APOTHEKE EUROPE. Stefan Feltens, CEO SHOP APOTHEKE EUROPE.
Slide 16: Leading Positions in Europe
SHOP APOTHEKE EUROPE TODAY. Leading Positions in Europe. • Undisputed market leader In Belgium. • Undisputed market leader In Austria. • Largest and most visited pharmacy webshop In Germany. JOINT VENTURE WITH GALENICA TO BECOME THE LEADING ONLINE PHARMACY IN SWITZERLAND.
Slide 17: Europe's One-Stop Pharmacy of the Future
SHOP APOTHEKE EUROPE: Europe‘s One-Stop Pharmacy of the Future. Combining OTC, BPC & Rx offerings. Leadership position in Europe. 7 countries. Approaching 10 million active customers. Continuously strong NPS of 72. More than 2,000 employees. Sales of 1,2 billion € in 2022. Share price development si
Slide 18: More Customers, Higher Market Shares
Active Customers (millions). More Customers, Higher Market Shares. 9.3 7.9 6.3 4.7 3.5 2.4 1.8 1.3 2015 2016 2017 2018 2019 2020 2021 2022
Slide 19: Our Mission
Our Mission. We enable everyone to live the healthiest life possible.
Slide 20: From a Pure Online Retailer to Europe's Leading E-Pharmacy Platform
FROM A PURE ONLINE RETAILER … … TO EUROPE‘S LEADING CUSTOMER- CENTRIC E-PHARMACY PLATFORM.
Slide 21: iin, NOW! ) @, Puls
y “ iin, NOW! ) @, Puls / SAME-DAY DELIVERY. 7 MARKETPLACE. , > rsp, smart manace. Patient MENT. MyTherapy SHOPPING APP. , =‘ ONLINE DOCTORS.
Slide 22: Commitment to Net-Zero by 2040
COMMITTED TO 1.5 DEGREES. Commitment to Net-Zero by 2040. • Reduction of scope 1 and 2 carbon emissions of 80% achieved three years ahead of plan. • MSCI ESG rating AAA. Michaela Tünnermann Pharmacist.
Slide 23: Presentation of Mediservice
Presentation of Mediservice. André Lüscher, CEO Mediservice.
Slide 24: The Leading Specialty Pharmacy in Switzerland
The Leading Specialty Pharmacy in Switzerland. Pharma Care Home Care Distance Care direct to patient delivery Patient support Telepharmacy Services. of prescription drugs. programmes at home.
Slide 25: Mediservice: The Leading Mail-Order Pharmacy in Switzerland
Mediservice: The Leading Mail-Order Pharmacy in Switzerland. • +12.9% YoY sales growth in 2022 in the area of rare diseases. • 700-1000 shippings a day. • Over 60 specialty indications.
Slide 26: Mediservice: We Care and Accompany Our Patients
Mediservice: We Care and Accompany Our Patients. • Constantly expanding services, moving from a highly specialised mail-order pharmacy to a Distance Healthcare Provider for chronic diseases. • Very high customer satisfaction score: 9.3/10 and high customer loyalty generating recurring sales. • We ca
Slide 27: Financial Details. Felix Burkhard, CFO GALENICA
Financial Details. Felix Burkhard, CFO GALENICA.
Slide 28: Transaction Structure
Transaction Structure. 51% Mediservice EUR 29 Mio. 2% Shop Apotheke 6% Shop Apotheke 8% Shop Apotheke Transfer shop-apotheke.ch to Mediservice, sale of 51% 51% 49% of Joint Venture against 6% of Shop Apotheke Capital increase 2% with cash settlement shop-apotheke.ch Target structure
Slide 29: 104% Commitment for our Customers
104% Commitment for our Customers. 8% 51% 49%
Slide 30: Galenica: Updated Guidance
Galenica: Updated Guidance. Revenue EBIT1) 4’014 +4% to +7% +3% to +6% 201 - 11% 446 1 - 5% 10 EBIT adjusted for IAS 19 and IFRS 16. 3’568 191 2022 2023 2022 2023 • P&L 2022 of Galenica will be restated, Mediservice will be deconsolidated and shown as discontinued operations. • Future EBIT will incl
Slide 31: Financial Details. Jasper Eenhorst, CFO SHOP APOTHEKE EUROPE
Financial Details. Jasper Eenhorst, CFO SHOP APOTHEKE EUROPE.
Slide 32: Number of Shares Pre- and Post-Transaction
Number of Shares at SHOP APOTHEKE EUROPE Pre- and Post-Transaction. +1.2 +0.4 • SHOP APOTHEKE EUROPE 20 new shareholder: 18.4 8% of shares outstanding, post-transaction. Million Shares Shares Pre- Post-
Slide 33: Financial Reporting at SHOP APOTHEKE EUROPE Post-Transaction
Financial Reporting at SHOP APOTHEKE EUROPE Post-Transaction. • In accordance with IFRS10, full consolidation of Mediservice AG figures as of deal closing date. • Current Mediservice business expected numbers for full year 2023: sales around CHF 450 million and EBITDA margin 2 to 3%. All sales are p
Slide 34: Financial Guidance 2023 of SHOP APOTHEKE EUROPE Reconfirmed
Financial Guidance 2023 of SHOP APOTHEKE EUROPE Reconfirmed. In Addition, Sales and EBITDA will Increase from the Transaction. Repeat of the outstanding guidance: • 10% to 20% growth in non-Rx sales (mid-point 15%). • Adj. EBITDA margin in the range of 0.5% to 2.5% (mid-point 1.5%). • Free cash flow
Slide 35: Conclusion
Conclusion. Stefan Feltens, CEO SHOP APOTHEKE EUROPE.
Slide 36: Introducing the Leading Online Pharmacy in Switzerland
Introducing the Leading Online Pharmacy in Switzerland. • Based on a strategic partnership that creates a real B2C powerhouse in the swiss online pharmacy market. • Combining two strong companies with unsurpassed specialty pharmacy expertise and top-notch e-commerce proficiency. • Offering a broader
Slide 37: EUROPE
EUROPE
Shop Apotheke Europe — Merger or Acquisition (March 2023) on 6ix